These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 12833133

  • 1. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
    Liu X, Tian PK, Ju DW, Zhang MH, Yao M, Cao XT, Gu JR.
    Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
    [Abstract] [Full Text] [Related]

  • 2. Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection.
    Liu X, Tian P, Yu Y, Yao M, Cao X, Gu J.
    Cancer Gene Ther; 2002 Jan; 9(1):100-8. PubMed ID: 11916239
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
    Wang L, Qi X, Sun Y, Liang L, Ju D.
    Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X, Ju DW, Tao Q, Wang J, Wan T, Wang BM, Zhang W, Hamada H.
    Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
    [Abstract] [Full Text] [Related]

  • 5. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
    Tai KF, Chen PJ, Chen DS, Hwang LH.
    J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
    [Abstract] [Full Text] [Related]

  • 6. Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.
    Chi CH, Wang YS, Lai YS, Chi KH.
    Anticancer Res; 2003 May; 23(1A):315-21. PubMed ID: 12680230
    [Abstract] [Full Text] [Related]

  • 7. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X, Huang X, Ju DW, Zhang W, Hamada H, Wang J.
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM.
    Cancer Gene Ther; 1999 Feb; 6(1):81-8. PubMed ID: 10078967
    [Abstract] [Full Text] [Related]

  • 9. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [Abstract] [Full Text] [Related]

  • 10. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 11. [Study on the effects of combined IL-12 and GM-CSF gene therapy for murine liver cancer].
    Qiu S, Ye S, Wang Z, Tang Z, Lu L, Xiao X.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec 15; 10(6):413-6. PubMed ID: 12502439
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J, Wu JH, Bouganim N, Galipeau J.
    Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233
    [Abstract] [Full Text] [Related]

  • 13. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity.
    Nakazaki Y, Tani K, Lin ZT, Sumimoto H, Hibino H, Tanabe T, Wu MS, Izawa K, Hase H, Takahashi S, Tojo A, Azuma M, Hamada H, Mori S, Asano S.
    Gene Ther; 1998 Oct 15; 5(10):1355-62. PubMed ID: 9930341
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.
    Clin Cancer Res; 2006 Nov 15; 12(22):6808-16. PubMed ID: 17121902
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 15; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
    Kim JM, Lee M, Kim KH, Ha Y, Choi JK, Park SR, Park H, Park HC, Ahn CH, Kim SW, Choi BH.
    J Control Release; 2009 Jan 05; 133(1):60-7. PubMed ID: 18938203
    [Abstract] [Full Text] [Related]

  • 17. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.
    Cancer Gene Ther; 2000 Sep 05; 7(9):1279-85. PubMed ID: 11023201
    [Abstract] [Full Text] [Related]

  • 18. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.
    Nemeckova S, Smahel M, Hainz P, Mackova J, Zurkova K, Gabriel P, Indrova M, Kutinova L.
    Neoplasma; 2007 Sep 05; 54(4):326-33. PubMed ID: 17822323
    [Abstract] [Full Text] [Related]

  • 19. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
    Withoff S, Glazenburg KL, van Veen ML, Kraak MM, Hospers GA, Störkel S, de Vries EG, Wilschut J, Daemen T.
    Gene Ther; 2001 Oct 05; 8(20):1515-23. PubMed ID: 11704811
    [Abstract] [Full Text] [Related]

  • 20. Gene therapy with tumor vaccine increases the survival of hepatoma-bearing mice.
    Chao Y, Shih YL, Cheng HJ, Wei SJ, Chi KH, Yeh SH, Lee SD, Yang WK.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct 05; 62(10):682-9. PubMed ID: 10533297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.